Neurotransmitter precursor therapies in affective disorders.
von Lerber-Good
W F
WF
D000293:Adolescent; D000328:Adult; D000368:Aged; D000588:Amines / Q000502:physiology; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004644:Emotions; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D019964:Mood Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D018377:Neurotransmitter Agents / Q000502:physiology*; D009638:Norepinephrine / Q000502:physiology; D011498:Protein Precursors / Q000627:therapeutic use; D012701:Serotonin / Q000502:physiology; D013569:Synapses / Q000502:physiology; D014364:Tryptophan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014443:Tyrosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000588:Amines; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D011498:Protein Precursors; D012701:Serotonin; D014443:Tyrosine; D014364:Tryptophan; D002262:Carboxy-Lyases; D009638:Norepinephrine